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ABSTRACT 13 
Biosurfactants are naturally-produced molecules that demonstrate potentially useful properties such as the ability to 14 
reduce surface tensions between different phases.  Besides having similar properties to their artificial chemical 15 
counterparts, they are regarded as environmental friendly, biodegradable and less toxic, which make them desirable 16 
candidates for downstream applications. The structure-activity related properties of the biosurfactants which are 17 
directly correlated with potency of the biosurfactants as antimicrobial agents, the ability of the biosurfactants to alter 18 
surface energies and their ability to increase bioavailability are particularly what attract researchers to exploit their 19 
potential use in the oral-related health applications. Current research into biosurfactant indicates significant future 20 
potential for use in cosmetic and therapeutic oral hygiene product formulations and related medical device 21 
treatments. 22 
 23 
 24 
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INTRODUCTION 25 
Naturally occurring surfactants, often referred to as biosurfactants, are amphipathic in nature (one molecule 26 
composed of two moieties; one hydrophilic and the other hydrophobic). This unique structural arrangement is 27 
directly related to the surface activities of these molecules, such as reducing the surface tension between different 28 
interface systems and their ability to form emulsions (Banat et al. 2010). The main classification of biosurfactants 29 
into two sub-groups is based on their molecular weight: compounds of low molecular weight, such as rhamnolipids, 30 
sophorolipids, lipopeptides and trehalolipids while other compounds such as lipoprotein and polymeric surfactants 31 
which comprise the high molecular weight groups (Fracchia et al. 2012). Due to the structure-activity related 32 
properties of biosurfactants there is an increasing interest in exploring the biomedical activities of these compounds 33 
such as antiviral, antimicrobial, antifungal and anticancer properties (Singh and Cameotra 2004; Fracchia et al. 34 
2014, 2015, Callaghan et al. 2016).  35 
Synthetic surfactants from non-renewable resources constitute the major component of an estimated more than 13 36 
million tonnes annual worldwide market (Marchant and Banat 2012a). To achieve a more competitive role for 37 
biosurfactants in this enormous market it will be necessary to improve scale up production conditions and explore 38 
new applications for environmentally sustainable and less damaging biosurfactants which can positively contribute 39 
towards reducing reliance on the synthetic surfactants (Marchant and Banat 2012b). In this review we attempt to 40 
briefly assess the progress that has been achieved in applying biosurfactants in the area of oral-related health 41 
applications.  42 
 43 
Oral-related health and hygiene issues 44 
The oral cavity harbours a wide and diverse spectrum of microorganisms (Wright et al. 2013). The natural presence 45 
of an oral microflora is important for normal survival of the host (Marsh 2000). Various mechanisms have been 46 
identified as being responsible for this contribution towards normal status of health in the individual. Primarily, the 47 
balance of populations within the oral microflora is carefully maintained. Therefore, populations present as a minor 48 
component are prevented from proliferating and disrupting the normal microflora, an example of which would be 49 
when use of antibiotics leads to the overgrowth of yeasts (Marsh 2010). Caries which arises from the disruption of 50 
the oral microflora balance can potentially be avoided through diet control and the use of fluoride enriched products 51 
(Bowden 2000). Furthermore, oral hygiene should be maintained through regular use of oral hygiene products. Such 52 
practices can provide control of plaque growth and inhibit bacterial proliferation associated with dental disease and 53 
can be achieved without eradicating beneficial bacteria or disrupting the microbial balance (Marsh et al. 2015; 54 
Marsh 2010). 55 
Microbes can be in a planktonic or biofilm state. Planktonic microorganisms are less difficult to deal with 56 
since they are loosely attached to oral tissue or dental surfaces, whereas fungal or bacterial oral biofilm (dental 57 
plaque) provides protection for the resident microorganisms which makes them less susceptible to hygienic 58 
practices and bioactive ingredients of the products used (Socransky and Haffajee 2002). Under normal physiological 59 
conditions saliva conditioning film forms on the dental substratum, known as acquired pellicle which is mainly 60 
characterised by a protein rich content that allows bacterial adhesion through specific receptors (Kreth et al. 2009). 61 
This is followed by co-aggregation and co-adhesion of different types of initial colonisers (e.g. Streptococci and 62 
members of the Actinomyces family) on the dental surface, which may lead to an irreversible adhesion where 63 
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microorganisms surround themselves with an extracellular polymeric substances (EPS) as a scaffold for the biofilm 64 
(Kolenbranderet et al. 2010), which is mainly composed of polysaccharides, proteins, nucleic acids and lipids 65 
(Flemming H-C et al. 2010). Biofilm development also involves the presence of bridging colonisers (such as 66 
Fusobacteria), which play an important role in co-adhesion and coaggregation processes, with cell surface proteins 67 
providing multi-binding points for such microorganisms (He et al. 2012). 68 
Normally the oral cavity environment provides protective mechanisms that maintain the normal 69 
physiological status, an example of which would be the secretion of natural peptides such as α-defensins, β-70 
defensins (Tao et al.2005). This innate protection is also partly related to the presence of biosurfactant-releasing 71 
microorganisms such as Streptococcus mitis, which effectively discourages the adherence of Streptococcus mutans, 72 
an important cariogenic bacterium (Reid et al. 2011). A similar important role in the innate maintenance of oral 73 
health is also carried out by some Lactobacillus species (Haukioja 2010) some of which are known to be 74 
biosurfactant producers (Satpute et al. 2016b). 75 
 76 
 Potential Biosurfactant applications for oral health and hygiene 77 
Several reports have demonstrated the ability of biosurfactants to inhibit and/or kill microorganisms, for example 78 
with natural lipopeptides (Cochrane et al. 2015; Banat et al. 2014), rhamnolipids (Díaz De Rienzo et al. 2016a,b) 79 
and Sophorolipids (Díaz de Rienzo et al. 2014, 2016c). It has also been reported that they are able to alter a 80 
substrate’s surface energy (Busscher and van der Mei 1997) and increase surface area (Rodrigues et al. 2006), 81 
which would make biosurfactants important potential candidates for oral health-related applications. A direct 82 
application of the latter properties is adjuvant delivery of antibiotics using biosurfactants, resulting in a reduced 83 
therapeutic dosage of antibiotics (Quinn et al. 2013). In this context, sophorolipids demonstrated potency when 84 
delivered in a pharmaceutical formulation where they acted synergistically with antibiotics such as Tetracycline and 85 
Cefaclor showing an increase in the permeability of the antibiotics across the outer membrane of the bacteria (Joshi-86 
Navare et al. 2003). It must be noted, however that in this study the sophorolipids used were not highly purified and 87 
the results should be treated cautiously. In a closely related area, biosurfactant properties (such as the ability to 88 
inhibit microorganisms and alter surface energy) have been shown to be of vital importance in controlling biofilm 89 
formation and proliferation (Satpute et al. 2016a). This was demonstrated when voice prostheses, prone to 90 
colonisation by oral bacteria and fungi (Bertl et al. 2013), were treated with biosurfactants (Rodrigues et al. 2006).  91 
A summary account of biosurfactant performance and effects in oral-related applications is presented in Table 1. 92 
This search has clearly demonstrated that the application of biosurfactants in oral-related health is still at an 93 
early stage. However, published work in this area is promising and developing. Prior to looking at the pros and cons 94 
of the available research, it should be recognised and appreciated that working in biosurfactant research is a 95 
complex multidisciplinary area of work. There is a substantial requirement for analytical method development and 96 
production optimisation, which may be challenging and muddled by some research groups. This is something that 97 
has been noted and commented upon by other authors (Marchant et al. 2014). An overview examination of related 98 
published work reveals that a substantial portion of the working this field is related to biosurfactants from Bacillus 99 
strains producing glycoprotein-type biosurfactants.  100 
A major problem in many studies is the lack of evidence of complete purity or characterisation of the 101 
biosurfactant active fractions used, as in the case of the work carried out by Tahmourespour (2011), Savabi (2014) 102 
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and Salehi (2014) and their co-workers when they investigated the gene expression gtfB and gtfC of S. mutans, 103 
which are directly involved in biofilm matrix formation. In principle, these studies are unique in being the first to 104 
investigate oral-related bacterial gene expression, after treatment with biosurfactant. However, the studies did not 105 
specify the relationship between the applied concentration of biosurfactant fraction used in the study and the 106 
minimum inhibitory concentration of that fraction against S.mutans, which is an important factor to understand and 107 
interpret the data obtained. The biosurfactant applied in these studies was characterised by Fourier Transform 108 
Infrared Spectroscopy (FTIR), and described as “protein-like” biosurfactant. However, FTIR as a stand-alone 109 
technique is very limited for the purpose of characterisation (Barth 2007). It is worth mentioning that Nuclear 110 
Magnetic Resonance spectroscopy (NMR) should be used for full characterisation of macromolecules such as 111 
lipoprotein. These protocols have been reviewed in detail by Twine and colleagues (2010). Also techniques such as 112 
one-dimension H1-NMR or C13-NMR are frequently used to characterise low molecular weight molecules, such as 113 
lipopeptide acting against S. mutans biofilm, for example as reported by Pradhan and colleagues (2013). However, 114 
such techniques should be used alongside other techniques such as HPLC-MS and in all cases compounds with high 115 
purity are needed especially in the case of NMR characterisation, as data obtained from crude extract experiments 116 
are not always meaningful. 117 
In a relatively close area, Rodrigues and co-workers investigated a biosurfactant-type described as 118 
glycoprotein from the probiotic bacteria Lactococcuslactis53 and Streptococcus thermophiles A. The active fraction 119 
of the biosurfactant produced demonstrated antimicrobial properties against a number of orally-related species (e.g. 120 
Streptococcus salivarius GB 24/9). Interestingly, when these fractions were used to precondition an artificial model 121 
voice prosthesis, it became evident that microorganisms were discouraged from forming a biofilm on the treated 122 
surface. Rodrigues and her colleagues (2006) used an expanded characterisation approach for the biosurfactant 123 
fractions, where Hydrophobic Interaction Chromatography (HIC) and X-ray Photoelectron Spectroscopy were used 124 
for characterisation purpose together with FTIR.Antimicrobial and antiadhesive activities of the biosurfactant crude 125 
extract were investigated against several pathogens, some of which were oral-related opportunistic microorganisms. 126 
In another study, Cochis and his colleagues (2012) demonstrated the antimicrobial and antibiofilm efficacy 127 
of biosurfactant produced by endophytes, selected from the plants Robinia pseudoacacia and Nerium oleander 128 
against Candida albicans, grown on elastomer silicon or denture disks. Good efficacy was shown at a low 129 
concentration of 78.12 µg ml
-1
, which has demonstrated a low toxicity as well. However, biosurfactant 130 
characterisation details were not mentioned. In a similar study Rufino and co-workers (2011) reported the 131 
production of the biosurfactant Rufisan from the yeast Candida lipolytica UCP 0988, although characterisation 132 
details were not mentioned. This biosurfactant showed efficacy as an antimicrobial and antibiofilm agent for a wide 133 
spectrum of pathogens, including orally-related microorganisms. Dusane et al (2012) investigated the effect of 134 
rhamnolipids on Yarrowia lipolytica biofilm formation on different surfaces, where rhamnolipids caused an 135 
inhibition of Yarrowia lipolytica biofilm production on plastic and glass by 50% and 67% respectively. The report 136 
does not provide insight into the chemical composition of the rhamnolipids used. 137 
In the same context, Busscher’s research group carried out interesting work in this field. An example of 138 
this is the early report of the investigation of the of adhesion of some Candida strains, isolated from naturally 139 
colonized voice prostheses, to silicone rubber with and without a salivary conditioning film in the absence and 140 
presence of an adhering biosurfactant-releasing by the dairy isolate Streptococcus thermophiles B (Busscher et al. 141 
1997). The same research group has also concluded in another study that the biosurfactant-releasing and naturally 142 
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oral cavity dwelling S. mitis can discourage the adhesion of S. mutans. The released biosurfactant from S. mitis was 143 
not fully characterised. However, based on preliminary analysis it was described as a rhamnolipid-like 144 
biosurfactant. When S. mitis was deposited on a glass surface (1- 4% surface coverage) in the presence of S. mutans, 145 
it was found that the adhesion of S. mutans was drastically inhibited at 20 mg ml
-1
. A reduction in S. mutans growth 146 
on a glass surface coated with biosurfactant released from S. mitis was also reported by van Hoogomoed and 147 
colleagues (2000). Interaction studies between dental surfaces coated with S. mitis biosurfactant and S. mutans using 148 
Atomic Force Microscopy (AFM), showed a remarkable increase in repulsion when S. mutans cells approached the 149 
dental surface (van Hoogomoed et al. 2006). Much of what is cited in this review deals with biosurfactants 150 
produced by Lactic Acid Bacteria (LAB). Beside their production of biosurfactants, these bacteria produce other 151 
organic substances such as bacteriocins. These help to maintain oral health for instance, through competing with 152 
pathogenic species for niches and nutrients, a topic that has been reviewed elsewhere (Badet and Thebaud 2008).  153 
In regards to oral cavity LAB secreting biosurfactants, the available literature does not appear to discuss 154 
the molecular pathways of synthesis of these surfactants, but rather emphasises the role they play in discouraging 155 
adhesion of pathogens (Satpute et al. 2016). Similarly, it is not fully clear why these bacteria produce biosurfactants 156 
in the oral cavity. However, by analogy to the role of rhamnolipids (mainly secreted by Pseodomonas aeruginsa) in 157 
the formation of biofilm structure which supports adhesion to surfaces (Davey et al. 2003); the secretion of 158 
biosurfactants from LAB, therefore may be carried out as an aid to help microorganisms that secrete them to adhere 159 
to the surface, which consequently helps to maintain the health of the host. In a direct application of biosurfactant in 160 
oral hygiene products a patented Emulsan formulation has shown a potent effect in plaque and caries control. It is 161 
thought that Emulsan inhibits the adhesion of S.mutans through the lectin-specific interaction with the galactose or 162 
galactosamine on the S.mutans cell surface (Eigen and Simone 1988). It is worth mentioning that these observations 163 
have not been scientifically reviewed. 164 
 165 
 Biosurfactants antimicrobial mode of action 166 
Understanding how an antimicrobial agent works, improves the prospects for application of the agents. Synthetic 167 
antimicrobials have been well investigated, including synthetic surfactants. The latter, in general terms, were found 168 
to compromise microbial cell surface integrity. Chlorhexidine, for example, an antimicrobial surfactant, was found 169 
to causes damage to the outer cell layer followed by penetration of the cell wall or outer membrane through passive 170 
diffusion, which leads to the coagulation and leakage of intracellular constituents. It is also evident from studies that 171 
only at high concentration does inactivation of ATPase occur, which suggests membrane disruption rather than 172 
enzymatic inactivation are associated with its mode of action (McDonnell and Russell1999). 173 
Biosurfactants are thought to follow a similar pattern in their antimicrobial mode of action. When in-vitro 174 
interactions between the antimicrobial lipopeptide surfactin (Carrillo et al. 2003) and trehalose biosurfactants (Ortiz 175 
et al. 2009) and the phospholipid bilayer were studied by Differential Scanning Calorimetry (DSC) and Fourier 176 
Transform Infrared Spectroscopy (FTIR), it was found that these interactions resulted in the incorporation of 177 
trehalose into the lipid membrane. This distorts the system’s native properties, with deformities leading to an 178 
increase in fluidity of the phosphatidylserine acyl chains and a decrease in the hydration of interfacial regions of the 179 
lipid bilayer. NMR interaction studies between deptomycin and the lipid membrane revealed similar findings, such 180 
as membrane conformational changes and membrane pore formation (Scott et al. 2007). 181 
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Biosurfactants may also affect the interaction of the microorganism with different surfaces through altering 182 
the hydrophobicity of the microorganism’s cell surface. In a detailed and informative review by Neu (1996), it was 183 
concluded that microorganism-surface interaction may happen through the biosurfactant anchoring by the 184 
hydrophobic or hydrophilic moiety, depending on the nature of the cell surface. Furthermore, the way the 185 
biosurfactants arrange themselves upon adsorption on surfaces may alter the surface nature depending on which part 186 
of the biosurfactant is extended to the exterior environment. Figure 1 illustrates these theoretical interactions along 187 
with the antimicrobial action of biosurfactant on the microbial surface. More recent reports still support this 188 
understanding, for example of the effects observed on Pseudomonas aeruginosa NBIMCC 1390, when treated with 189 
a concentration of rhamnolipids above their Critical Micelle Concentration (CMC) (which caused an increase in cell 190 
hydrophobicity, related to a reduction in the total LPS). Rhamnolipids were also effective below their CMC 191 
concentration as they caused a notable reduction in the bacterial major outer membrane proteins (OMP) (Sotirova et 192 
al. 2009). 193 
 194 
CONCLUSION 195 
Research findings in this area reveal that biosurfactants have the potential to be applied in different oral-related 196 
areas. Biosurfactant properties such as: antimicrobial activity whether biocidal or biostatic and against both Gram 197 
positive and Gram negative bacteria, emulsion-forming capability to create either stable or metastable 198 
microemulsions  and the ability to increase bioavailability of hydrophobic compounds, which results in a reduction 199 
of the effective concentrations of hydrophobic active ingredients in addition to some anticancer activities towards 200 
some cell lines, make biosurfactants potential candidates in cosmetic or therapeutic oral hygiene products and also 201 
oral-related medical devices. However, to optimise the applicability of these compounds, significant efforts are 202 
required to enhance the quality of research. Refining the research aspects in this area may attract sceptical industrial 203 
collaborators. If we are attempting to assign bioactivity to biosurfactants it is imperative that high purity, single 204 
molecule species preparations are used to ensure that the observed effects are not due to a random contaminant, 205 
which may vary from one production batch to another. This could be of great therapeutic value on its own and also 206 
if chemical modification of naturally available complex congeners is required to enhance the efficacy or to reduce 207 
potential toxicity. Furthermore, biosurfactants sterilization methods require further evidence-based understanding. 208 
 209 
 210 
 211 
 212 
 213 
 214 
 215 
 216 
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Table 1 – Summary Account of Biosurfactants in Oral-related Applications 
BS Type BS Producer Main Findings References 
Uncharacterised 
-glycoprotein-
type 
biosurfactants 
Lactobacillus 
casei 
(ATCC39392) 
Study investigates effect of biosurfactant-type on 
Streptococcus mutans gene expression of 
glucosyltransferase (gtfB and gtfC) and fructosyltransferase 
(ftf) genes (important genes for biofilm matrix formation). 
All genes found to have been dramatically down regulated 
upon the application of the biosurfactant. 
Savabi et al. 
2014 
Uncharacterised 
-glycoprotein-
type 
biosurfactants 
Lactobacillus 
acidophilus 
DSM 20079 
Experimentally identical to the above study, a similar 
conclusion was reached. 
Tahmourespo
ur et al. 2011 
Uncharacterised 
-glycoprotein-
type 
biosurfactants 
Lactobacillus 
reuteri 
(DSM20016) 
Experimentally identical to the above study, a similar 
conclusion was reached. 
Salehi et al. 
2014 
Uncharacterised 
-glycoprotein-
type 
biosurfactants 
Lactobacillus 
fermentum 
ATCC 9338 
 
Experimentally identical to the above, a similar conclusion 
was reached. 
Tahmourespo
ur et al. 2011 
Biosurfactant-
type 
 
Streptococcus 
mitis 
Upon coating enamel surface with biosurfactant from natural 
oral cavity resident bacterium, Streptococcus mitis, the 
surface became less attractive to S. mutans cells as repulsive 
forces increased. 
van 
Hoogmoed et 
al. 2006 
Uncharacterised Candida 
lipolytica 
UCP0988 
Study showed the ability of the biosurfactant to induce 
noticeable inhibition of several Lactobacillus strain biofilm 
and Streptococcus mutans HG985 at different 
concentrations. 
Rufino et al. 
2011 
Uncharacterised Lactobacilluspa
racasei A20 
 
 
Antimicrobial and anti-adhesive activities of the 
biosurfactant crude extract were investigated against several 
pathogens; some of those are oral-related opportunistics. 
The study investigated concentrations between 25 and 50 
mg ml
-1
, which demonstrated good efficacy in vitro. 
Gudina et al. 
2010 
Partially 
characterised - 
glycoprotein 
Lactococcus 
lactis 53 and 
Streptococcus 
thermophilus A 
Biofilms were grown on preconditioned voice prostheses, 
with biosurfactants obtained from the probiotic bacteria 
Lactococcus lactis 53 and Streptococcus thermophilus A, in 
an artificial throat model. Both biosurfactants greatly 
reduced microbial numbers on prostheses and also induced a 
decrease in the airflow resistance that occurs on voice 
prostheses after biofilm formation. 
Rodrigues et 
al. 2004 
Partially 
characterised - 
glycoprotein 
Lactococcus 
lactis 53 
Study demonstrated efficacy of the extracted biosurfactant 
(previously described in Rodrigues et al, 2004) against 
microorganism isolated from an explanted voice prosthesis. 
Rodrigues et 
al. 2006 
Mixture of 
Glycosidic 
residue and 
Rhamnolipidlik
e 
mixture 
Streptococcus 
mitis 
Study demonstrated how the S. mitis biosurfactant-releasing 
species significantly inhibited growth of S. mutans on a 
glass surface. 
van 
Hoogmoed et 
al. 2000 
Uncharacterised 
biosurfactant 
Robinia 
Pseudoacacia 
(AC5 and AC7) 
and Nerium 
oleander 
(OC5) 
Prevention of biofilm formation of silicon and acrylic resin 
for dental prostheses 
Cochis et al, 
2012 
Lipopeptide Bacillus 
tequilensis 
Inhibition of S. mutans biofilm at concentration of 50µg/ml 
at different hydrophobic and hydrophilic surfaces 
Pradhan et al. 
2003 
Uncharacterised 
Rhamnolipid 
Pseudomonas 
aeruginosa 
50% and 67% inhibition of fungal Yarrowia lipolytica 
biofilm formation on 96 well plate surface and glass surface 
Dusane et al. 
2012 
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respectively, in a pre-coating experiment. 
 
Emulsan Unidentified 
(usually 
produced by 
Acinetobacter 
calcoaceticus) 
Control of dental plaque and caries  
 
US 4737359 
A. Patent 
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Fig 1: (1) Represents the mechanisms through which biosurfactants can affect the inhibition of microorganism growth on 
surfaces. (A1) demonstrates how, in natural settings, when a microorganism secrets biosurfactant as a means of survival it may 
discourage other pathogens from adhering to the surface. The two coloured shapes (Circular and rod) representing two 
different types of microorganism and the thinner line above the base (surface) represents the secreted biosurfactant. (B1) 
represents the ability of the biosurfactant to disrupt biofilm through affecting the cell surface. The circular and rod shapes 
represent different types of microorganism and the circular shape attached to a straight line represents biosurfactant showing an 
amphiphilic structure with a head (circular) and tail (straight line), (this applies to all figures). (C1) Illustrates the ability of the 
surface-coated with biosurfactant to inhibit microorganisms. (B1) and (C1) are further explained by (3) and (4). (2) Represents 
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the direct antimicrobial effect of biosurfactant on the microorganism. The bacterial cell membrane that has been disrupted by a 
biosurfactant, it also shows the disruption of ion flow and passage of large molecules to the exterior environment as a result of 
membrane disruption. (3) and (4) adopted from (Neu 1996). In (3) orientation of the biosurfactant through which it may anchor 
into the microorganism cell surface and may enhance or inhibit the adhesion depending upon the interaction between the 
biosurfactant-influenced cell surface and the surface under investigation. In (4), upon applying the biosurfactant to surfaces, 
the biosurfactant may adhere using the hydrophobic moiety or the hydrophilic moiety depending on the surface type, this as a 
result will influence the type of interaction between the coated surface and the microorganism. In both (3) and (4), the 
unfavourable route of adhesion has been cross marked.  
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